{{Rsnum
|rsid=363096
|Gene=HTT
|Chromosome=4
|position=3178294
|Orientation=minus
|GMAF=0.4568
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=HTT
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 24.8 | 40.7 | 34.5
| HCB | 36.5 | 48.2 | 15.3
| JPT | 36.3 | 50.4 | 13.3
| YRI | 6.8 | 44.9 | 48.3
| ASW | 15.8 | 43.9 | 40.4
| CHB | 36.5 | 48.2 | 15.3
| CHD | 33.0 | 51.4 | 15.6
| GIH | 35.6 | 44.6 | 19.8
| LWK | 10.9 | 39.1 | 50.0
| MEX | 15.5 | 53.4 | 31.0
| MKK | 12.2 | 50.0 | 37.8
| TSI | 20.6 | 43.1 | 36.3
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs363096
|Name_s=
|Gene_s=HTT
|Feature=
|Evidence=PubMed ID:19249009
|Annotation=This SNP is part of a haplogroup found to be associated with CAG repeat number expansion in Huntington disease (36 or more CAG repeats) in Europeans. This SNP itself was significantly associated(p < 0.0023) with the expansion.
|Drugs=
|Drug Classes=
|Diseases=Huntington Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA164918150
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs363096
|overall_frequency_n=5907
|overall_frequency_d=9638
|overall_frequency=0.612886
|n_genomes=44
|n_genomes_annotated=0
|n_haplomes=62
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}